1.Ophiopogon japonicus (L. f.) Ker Gawl. extract treats dry eye disease via anti-inflammatory, antioxidant, and goblet cell-stimulating effects
Guoliang Li ; Rui Feng ; Jiayi Yu ; Boliang Li ; Yanni Luo ; Hongyi Luo ; Cheng Zhang ; Guanghong Zhang ; Jianglong Li ; Chao Qu
Journal of Traditional Chinese Medical Sciences 2025;2025(3):422-433
ObjectiveTo investigate the anti-inflammatory, antioxidant, and goblet cell-stimulating effects of a suspension of Ophiopogon japonicus (L. f.) Ker Gawl. (O. japonicus, Mai Dong) extract combined with hyaluronic acid (HA) in the mouse model with dry eye disease (DED).MethodsA DED mouse model was induced using benzalkonium chloride (BAK), followed by treatment with O. japonicus extract-containing eye drops at varying concentrations. Experimental groups included a normal control, a DED model control, a positive control, and an O. japonicus extract-treated group. Corneal fluorescein staining and tear break-up time (TBUT) were used to assess tear film stability and ocular surface integrity. Enzyme-linked immunosorbent assay (ELISA) measured inflammatory factor levels in corneal and conjunctival tissues, whereas Western blot (WB) analyzed key antioxidant and inflammatory markers, including nuclear factor erythroid 2-related factor (2Nrf2) and heme oxygenase 1 (HO-1). Periodic acid-schiff (PAS) staining and immunofluorescence were used to evaluate goblet cell density and mucin secretion.ResultsO. japonicus extract significantly improved corneal damage, reduced fluorescein staining scores, prolonged TBUT, and increased tear secretion. It downregulated inflammatory markers, including interleukin-8 (IL-8), interleukin-1β (IL-1β), and interferon-γ (IFN-γ) while upregulating Nrf2, HO-1, and the interleukin-13 (IL-13)/IFN-γ ratio, alleviating oxidative stress and inflammation. PAS staining showed increased conjunctival goblet cell density and restored mucin secretion, enhancing tear film stability.ConclusionO. japonicus extract demonstrated significant anti-inflammatory, antioxidant, and goblet cell-stimulating effects in a DED model, with good biocompatibility and promising therapeutic potential. Future research should optimize extraction processes and validate their efficacy and safety in clinical settings.
2.Study on the Pharmacodynamic Substances and Quality Control of Shenfukang II Capsules Based on Fingerprint and Network Pharmacology
YIN Jiyao ; HU Jing ; SHEN Xia ; CUI Xiaomin ; REN Hui ; QU Tong ; LI Ning ; LU Wenjin ; CHEN Zhiyong
Chinese Journal of Modern Applied Pharmacy 2023;40(13):1765-1774
OBJECTIVE To establish the fingerprint of Shenfukang Ⅱ capsule(SC-Ⅱ), and to screen out its indicative compounds for quality control combined with chemometrics methods and network pharmacology. METHODS The HPLC fingerprint of 10 batches of SC-Ⅱ was established, and similarity evaluation was analyzed by Similarity Evaluation System for Chromatographic Fingerprint of TCM(2012 A Edition) to determine common peaks; common peaks were identified through standard comparison. Chemometrics methods was used to evaluate quality of 10 batches of SC-Ⅱ, and network pharmacology was used to screen out core targets and pathways of SC-Ⅱ. Combined with the above results, indicative compounds for quality control of SC-Ⅱ were screened out. RESULTS A total of 37 common peaks were obtained in the HPLC fingerprint, the similarity of samples was greater than 0.97. Twenty compounds were identified as morroniside, loganin, paeoniflorin and et al. The samples were divided into two categories by chemical pattern recognition, salvianolic acid B, morroniside, salvianolic acid A and paeoniflorin were differential marker compounds for SC-Ⅱ. Network pharmacology predicted that active compounds such as salvianolic acid B, paeoniflorin and morroniside might exert pharmacological effects through 45 core targets and 15 main pathways. The research preliminary preliminarily predicted that morroniside, paeoniflorin and salvianolic acid B were quality control index components for SC-II. CONCLUSION The established HPLC fingerprint method is simple and good repeatability. The quality control indicative compounds of SC-Ⅱ can provide a basis for its quality control.
3.Endoscopic thoracic sympathicotomy in the treatment of primary hyperhidrosis based on ambulatory surgery and enhanced recovery mode: A retrospective cohort study in a single center
Anping CHEN ; Ming GONG ; Lan LI ; Cheng CHEN ; Wendong QU ; Xu HAN ; Yongxiang SONG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2022;29(03):301-305
Objective To investigate the safety of endoscopic thoracic sympathicotomy in the treatment of primary hyperhidrosis based on ambulatory surgery mode. Methods Retrospective analysis was performed on the clinical data of 158 patients with primary hyperhidrosis who received endoscopic thoracic sympathicotomy in the Affiliated Hospital of Zunyi Medical University from January 2019 to March 2021. There were 68 (43.2%) males and 90 (56.8%) females with an average age of 14-33 (20.5±3.1) years. The basic information of the patients, operation time, intraoperative blood loss, postoperative pain score, hospitalization expenses and postoperative complications were observed and recorded. Results All surgeries were successfully completed and the patients were discharged as planned. The operation time was 41.8±13.9 min, the intraoperative blood loss was 10.5±7.3 mL, the postoperative anesthesia recovery time was 15.0±5.9 min, and the pain score was 3.0±0.9 points. The total length of hospitalization was 1.6±1.0 days. The total postoperative expenses were 9 471.7±1 698.9 yuan. Pneumothorax occurred after the operation in 3 patients. Telephone follow-up on the 30th day after the operation showed no recurrence of sweaty hands, pneumothorax or rapid heart rate, and no serious complications or death related to the day operation within 30 days after the operation. Conclusion Endoscopic thoracic sympathicotomy based on ambulatory surgery mode is safe and effective in the treatment of primary hyperhidrosis.
4.Molecular epidemiological analysis of mycoplasma infection in female reproductive tract in Xi39;an
Libin WANG ; Chao LI ; Lei QU ; Qi WANG ; Yun XIE
Journal of Public Health and Preventive Medicine 2020;31(6):96-99
Objective To analyze the molecular epidemiological characteristics of mycoplasma infection in female reproductive tract in Xi'an. Methods Women suspected to be infected with mycoplasma who were admitted to the gynecological outpatient department of Northwest Women's and Children's Hospital and underwent genital mycoplasma detection in the testing center from January 2018 to January 2019 were enrolled. General demographic characteristics and 16S rDNA results were collected. Results Among 174 women, 58 cases were positive for mycoplasma, with a detection rate of 33.33% (58/174). A total of 36 cases were positive for Ureaplasma urealyticum (Uu), with a detection rate of 20.69%. A total of 39 cases were positive for Mycoplasma hominis (Mh), with a detection rate of 20.09%. A total of 12 cases were positive for Mycoplasma gentiformis (Mg), with a detection rate of 6.90%. The positive rates in all groups included single or mixed infection cases. The positive rates of mycoplasma and Uu in patients with genital tract inflammation, pregnancy and menopause were higher than those in patients without reproductive tract inflammation, pregnancy or menopause (P<0.05). There was no significant difference in the positive rate of mycoplasma infection in patients with different age, nationality, household registration nature, occupation, smoking history, drinking history, education level, family monthly income, chief complaint, and birth history (P>0.05). None of these factors affected the positive rates of mycoplasma, Uu, Mn or Mg. Conclusion Women with reproductive tract mycoplasma infection were mainly caused by mycoplasma, Uu and Mh, which are symbiotic bacteria of female genital tract, and do not show the specificity of age, fertility, menopause and various inflammation of genital tract.


Result Analysis
Print
Save
E-mail